/
/
Geração de Arenavirus recombinante de Desenvolvimento de Vacinas no FDA-approved células Vero
Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
Geração de Arenavirus recombinante de Desenvolvimento de Vacinas no FDA-approved células Vero
16,661 Views
•
10:03 min
•
August 01, 2013
DOI:
Tags
Recombinant ArenavirusVaccine DevelopmentFDA-approved Vero CellsArenavirus Reverse GeneticsCell-based Arenavirus Minigenome SystemsRecombinant Infectious ArenavirusesTrisegmented ArenavirusesSingle-cycle Infectious ArenavirusesReporter GenesPlasmid-based Reverse GeneticsRodent Cell LinesFDA-licensed VaccineVaccine Vectors
Read Article
Cite this Article
Cheng, B. Y., Ortiz-Riaño, E., de la Torre, J. C., Martínez-Sobrido, L. Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells. J. Vis. Exp. (78), e50662, doi:10.3791/50662 (2013).
Copy